| | 556743-18-1 Basic information More.. |
| Product Name: | Lumbrokinase | | Synonyms: | Lumbrokinase;lumbrokinase capsules;LuMbokinase capsules;GenBank AAP92795 (Translated from: GenBank AY327442);Lumbrukinase;Vermis;Lumbrokinase USP/EP/BP;Lumbrokinaseis | | CAS: | 556743-18-1 | | MF: | C12H15N3O2S | | MW: | 0 | | EINECS: | 211-390-9 | | Mol File: | Mol File |  |
Use
Potential clinical applications One of the most intensely researched areas is the use of lumbrokinase in the prevention and treatment of ischemic stroke patients. Lumbrokinase was shown to be safe and effective for treating acute ischemic stroke by lowering blood viscosity, preventing re-perfusion damage, and reducing neural deficits. It was also shown to improve the efficacy of aspirin as a secondary prevention of stroke.
- Lumbrokinase
-
- US $0.00-0.00 / g
- 2025-02-06
- CAS:556743-18-1
- Min. Order: 1g
- Purity: 98.0%
- Supply Ability: 1kg/month
- Lumbrokinaseis
-
- US $10.50 / KG
- 2024-10-11
- CAS:556743-18-1
- Min. Order: 1KG
- Purity: 99
- Supply Ability: 1 ton
- Lumbrokinase
-
- US $99.00-98.00 / Kg/Bag
- 2024-09-18
- CAS:556743-18-1
- Min. Order: 1Kg/Bag
- Purity: 98%
- Supply Ability: 500kg
|
|
556743-18-1
Recommend Suppliers |
|